Cardiovascular Intervention and Therapeutics

, Volume 30, Issue 2, pp 176–178

Extremely late (7 years) paclitaxel-eluting stent thrombosis

  • J. A. Linares Vicente
  • J. R. Ruiz Arroyo
  • B. Simó Sánchez
  • A. Lukic
  • P. Revilla Martí
Case Report

Supplementary material

12928_2014_270_MOESM1_ESM.avi (1.3 mb)
Video 1: initial left anterior descending artery angiography, showing thrombotic content at proximal edge and middle stent segment (AVI 1371 kb)
12928_2014_270_MOESM2_ESM.avi (1.6 mb)
Video 2: final angiographic result at left anterior descending artery after percutaneous coronary intervention (AVI 1660 kb)


  1. 1.
    Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med. 2006;354(5):483–95.CrossRefPubMedGoogle Scholar
  2. 2.
    Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Acad Res Consort Circulation. 2007;115(17):2344–51.Google Scholar
  3. 3.
    Otsuka F, Nakano M, Ladich E, Kolodgie FD, Virmani R. Pathologic etiologies of late and very late stent thrombosis following first-generation drug-eluting stent placement. Thrombosis. 2012;2012:608593.CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426–34.CrossRefPubMedGoogle Scholar
  5. 5.
    De la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, de Pérez Prado A, et al. Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2. JACC Cardiovasc Interv. 2010;3(9):909–11.Google Scholar
  6. 6.
    Schinkel AF, Barlis P, van Beusekom HM, Serruys PW, Regar E. Optical coherence tomography findings in very late (4 years) paclitaxel-eluting stent thrombosis. JACC Cardiovasc Interv. 2008;1(4):449–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Joyal D, Rudski L. Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation. J Invasive Cardiol. 2007;19(9):E265–7.PubMedGoogle Scholar
  8. 8.
    Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyakazi S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher registry. Circulation. 2012;125(4):584–91.CrossRefPubMedGoogle Scholar
  9. 9.
    Taylor-Sutton JE, Kim MC. Very late stent thrombosis approximately 7 years after deployment and one-week cessation of dual antiplatelet therapy. J Invasive Cardiol. 2011;23(12):E273–6.PubMedGoogle Scholar
  10. 10.
    Spagnoli V, Veugeois A, Caussin C, Amabile N. Extremely late drug-eluting stent thrombosis related to uncovered struts: the phantom menace. Eur Heart J. 2013;34(31):2428.CrossRefPubMedGoogle Scholar
  11. 11.
    Siddiqi OK, Faxon DP. Very late stent thrombosis: current concepts. Curr Opin Cardiol. 2012;27(6):634–41.CrossRefPubMedGoogle Scholar
  12. 12.
    Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113(8):1108–13.CrossRefPubMedGoogle Scholar
  13. 13.
    Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–30.CrossRefPubMedGoogle Scholar
  14. 14.
    Lee CW, Kang SJ, Park DW, Lee SH, Kim YH, Kim JJ, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol. 2010;55(18):1936–42.CrossRefPubMedGoogle Scholar
  15. 15.
    Costa MA, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Teirstein P, Carter A, et al. Intravascular ultrasound characterization of the “black hole” phenomenon after drug-eluting stent implantation. Am J Cardiol. 2006;97(2):203–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Zhang T, Shen L, Hu L, He B. Optimal duration of dual-antiplatelet therapy following drug-eluting stent implantation: a meta-analysis. J Clin Pharmacol. 2013;53(3):345–51.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Association of Cardiovascular Intervention and Therapeutics 2014

Authors and Affiliations

  • J. A. Linares Vicente
    • 1
  • J. R. Ruiz Arroyo
    • 1
  • B. Simó Sánchez
    • 1
  • A. Lukic
    • 1
  • P. Revilla Martí
    • 1
  1. 1.Interventional Cardiology Unit, Cardiology DepartmentClinic Universitary Hospital “Lozano Blesa”ZaragozaSpain

Personalised recommendations